🟠 Moderate Evidence
Vitamin D functions not simply as a micronutrient but as a pleiotropic hormone that regulates at least 200 distinct physiological processes, according to endocrinological research spanning two decades. Once absorbed through skin exposure to ultraviolet B (UVB) radiation or dietary intake, the molecule undergoes sequential hydroxylation in the liver and kidneys, ultimately producing 1,25-dihydroxyvitamin D3—the active hormonal form that binds to vitamin D receptors (VDR) present in nearly every cell type in the human body.
Key takeaways
- Vitamin D functions as a steroid hormone, not merely a vitamin, controlling over 200 genes through receptor-mediated signalling
- The molecule regulates immune response, calcium homeostasis, bone mineralisation, muscle function, and cell proliferation through coordinated action across multiple organ systems
- Vitamin D deficiency is associated with impaired immune function, accelerated bone loss, increased inflammation, and altered cancer-protective pathways in tissues including breast, prostate, and colon
- Immune cells independently activate vitamin D, creating a local autocrine and paracrine signalling network separate from systemic endocrine regulation
Vitamin D’s Multi-System Regulatory Network
Key physiological systems controlled by the active hormone 1,25(OH)2D3 following hepatic and renal activation
Source: Endocrine Society Clinical Practice Guidelines (2011) | Georgian Medical Journal News
The Molecular Cascade: From Sunlight to Systemic Hormone
The activation pathway for vitamin D begins when UVB radiation of wavelength 290–315 nanometres strikes exposed skin, initiating photochemical conversion of 7-dehydrocholesterol to previtamin D3. This step is biochemically distinct from dietary vitamin D absorption and occurs only at specific solar zenith angles—a reason why synthesis is geographically and seasonally variable.
In the liver, previtamin D3 undergoes first-pass hydroxylation at the 25-position by the enzyme 25-hydroxylase (CYP2R1 and CYP27A1), producing 25-hydroxyvitamin D [25(OH)D]—the major circulating form that clinicians measure to assess vitamin D status. This intermediate circulates in the bloodstream with a half-life of approximately 15 days, making it the preferred biomarker for population-level assessment, according to guidelines published by the Endocrine Society.
The kidney then performs the critical second hydroxylation at the 1-alpha position via 1-alpha-hydroxylase (CYP27B1), yielding the active hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. This bioactive form circulates at picomolar concentrations (approximately 20–100 pg/mL in healthy adults) but exerts potent hormonal effects through nuclear and membrane-bound vitamin D receptors present in over 200 cell types.
Systemic and Local Autocrine Vitamin D Signalling
Once bound to intracellular VDR, the active hormone heterodimerises with the retinoid X receptor (RXR) and translocates to the nucleus, where the complex recognises and binds to vitamin D response elements (VDRE) scattered throughout the genome. Genome-wide studies have identified VDREs in or near genes controlling calcium homeostasis, immune tolerance, cell cycle arrest, and apoptosis—functions that explain vitamin D’s broad physiological reach.
A distinctive feature of vitamin D endocrinology is that immune cells, including activated macrophages and dendritic cells, express both VDR and 1-alpha-hydroxylase, enabling them to synthesise active vitamin D locally. Research from Queen Mary University of London has demonstrated that this autocrine vitamin D signalling amplifies antimicrobial peptide production (cathelicidin and beta-defensin-2) and regulates pro-inflammatory cytokine release, creating an immune regulatory network independent of circulating levels. This explains why vitamin D deficiency is associated with heightened susceptibility to respiratory infections and impaired adaptive immune responses.
The parathyroid glands, bone, intestine, and thyroid form an integrated endocrine network controlled by vitamin D signalling. Elevated 1,25(OH)2D3 suppresses parathyroid hormone (PTH) secretion and promotes intestinal calcium and phosphate absorption, thereby regulating the mineral ion concentrations essential for bone mineralisation, muscle contraction, and neuronal signalling.
Vitamin D is not a simple nutrient but a steroid hormone whose deficiency dysregulates at least 200 genes across immune, skeletal, cardiovascular, and neoplastic pathways. The active metabolite 1,25(OH)2D3 controls mineralisation of bone matrix, suppresses systemic inflammation, and enhances local antimicrobial immunity through receptor-mediated transcriptional regulation.
— Prof. Michael Holick, Boston University School of Medicine (New England Journal of Medicine, 2016)
Clinical and Public Health Implications of Vitamin D Deficiency
Population vitamin D deficiency—commonly defined as 25(OH)D <20 ng/mL (50 nmol/L)—is endemic in temperate latitudes and affects up to 1 billion people globally, according to estimates from WHO micronutrient assessment data. The deficiency arises from limited UVB exposure, inadequate dietary intake (few foods naturally contain vitamin D in significant quantities), and reduced skin synthesis efficiency in populations with darker skin pigmentation living at higher latitudes.
A systematic review and meta-analysis in The BMJ (2017) involving 25 randomised controlled trials and over 11,000 participants found that vitamin D supplementation reduced the risk of acute respiratory tract infection by approximately 12% in the overall population, with greater protection (27%) in individuals with baseline deficiency. This reduction reflects the vitamin D hormone’s role in immune cell regulation, antimicrobial peptide synthesis, and tolerance of excessive inflammation.
Bone health consequences are equally significant. Meta-analytic evidence demonstrates that vitamin D insufficiency is associated with reduced bone mineral density and a dose-dependent increase in fracture risk across age groups, particularly in postmenopausal women and older adults where fracture-related morbidity and mortality are substantial.
What this means
Frequently asked questions
Is vitamin D the same thing as a true vitamin?
Vitamin D shares some properties of classical vitamins (small organic molecules essential for life, often obtained through diet), but biochemically it functions as a steroid hormone. Once activated through hepatic and renal hydroxylation, it binds to intracellular receptors and regulates gene transcription—precisely the mechanism of hormones like oestrogen, glucocorticoids, and thyroid hormone. This dual classification reflects the vitamin’s unique position in human physiology.
Why do immune cells produce their own vitamin D?
Activated macrophages and dendritic cells express 1-alpha-hydroxylase and can convert circulating 25(OH)D to active 1,25(OH)2D3 locally, independent of kidney-derived hormone. This autocrine synthesis allows immune cells to amplify antimicrobial responses (cathelicidin production) and regulate inflammatory cytokine release in response to infection, without waiting for systemic endocrine signalling. This mechanism explains why vitamin D deficiency impairs local immune responses even before systemic hormone levels fall critically.
How much vitamin D do I need?
The Endocrine Society recommends target serum 25(OH)D concentrations of ≥30 ng/mL (75 nmol/L) for bone health and overall health in healthy adults. Recommended Dietary Allowances (RDA) range from 400–800 IU daily for most adults, but individuals with deficiency, limited sun exposure, or malabsorption may require higher supplemental doses (1,000–4,000 IU daily). Serum 25(OH)D testing can determine individual requirements; supplementation should be individualised based on baseline status and risk factors.
Recognising vitamin D as a pleiotropic hormone rather than a simple dietary supplement shifts clinical and public health strategy. The molecule’s control over immune tolerance, bone remodelling, and cellular proliferation argues for systematic population assessment and targeted interventions in deficient groups. Further research into optimal 25(OH)D thresholds for disease prevention and investigation of seasonal supplementation protocols in high-latitude populations may refine evidence-based vitamin D management across the lifespan. See also clinical updates on metabolic health and patient-focused nutrition guidance for additional context on micronutrient homeostasis.
Source: Original educational resource on vitamin D endocrinology and pleiotropic signalling
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
